laboratory updates

laboratory updates



13 may

May 13, 2024 | Allergy Guidelines

13 may...

7 May

May 07, 2024 | Allergy Guidelines

7 may...

Lab Update 28 - A New Respiratory Virus Multiplex PCR

Jan 10, 2022 | Infectious Diseases

Ampath is implementing a respiratory viral multiplex PCR that includes SARS-CoV-2, Influenza A and B and RSV in a single test....

Lab Update 27 - CSF Cell Counts Notice to Clinicians

Dec 07, 2021 | Haemotology

Ampath NRL now performs CSF cell counts on an automated haematology analyzer....

Lab Update 24 - Laboratory diagnosis and monitoring of schistosomiasis in South Africa

Jul 01, 2021 | Chemical Pathology

The laboratory diagnosis of schistosomiasis is challenging and particularly difficult in the setting of early and low-grade infections. This update serves to provide an overview of the diagnostic process....

Lab Update 25 - COVID-19 Delta Variant

Jul 01, 2021 | Infectious Diseases

The Delta SARS-CoV-2 variant was first detected in India in October 2020, and has since spread to 85 countries globally. As a result of its enhanced transmissibility, it has rapidly become the dominant strain in many countries....

Lab Update 26 - COVID-19 vaccine side-effects: The essential facts

Jul 01, 2021 | Immunology

Social media is flooded with false information regarding the risks associated with the COVID-19 vaccination. Patients often turn to doctors for answers. If we are not able to address their concerns, patients may miss out on this potentially life-saving vaccination....

Lab Update 21 - Iron Deficiency in Pregnancy

May 01, 2021 | Allergy Guidelines

It is estimated that 30% of women of reproductive age have anaemia. Among pregnant women, the prevalence is even higher with the WHO estimating that over 40% of pregnant women globally have anaemia....

Lab Update 22 – LDL Cholesterol Targets

Mar 01, 2021 | Chemical Pathology

Low-density lipoprotein (LDL) cholesterol (LDL-C) is a well known target for therapy in patients with hyperlipidaemia. Retention of LDL-C and other cholesterol-rich apolipoprotein (Apo) B-containing lipoproteins within the arterial wall is considered an initiating event in atherogenesis....

Lab Update 19 - N-Terminal Procollagen-III Peptide

Aug 01, 2020 | Chemical Pathology

Type III collagen is an important component of connective tissue. N-terminal procollagen-III peptide (P3NP) is a cleavage product of the precursor of Type III collagen and is formed in equimolar proportions to Type III collagen. Serum levels of P3NP can therefore be used as a measure of Type III collagen and reflects the rate of extracellular matrix synthesis or breakdown....

Lab Update 20 - Adult HIV Diagnosis

Jul 01, 2020 | Chemical Pathology

The standard approach to the laboratory diagnosis of HIV infection in children older than 18 months and adults is to test for HIV infection by serological means, whereby the presence of HIV-specific antibodies in a patient’s blood specimen is determined by a screening enzyme-linked immunosorbent assay (ELISA). Screening HIV ELISA tests are designed to be extremely sensitive tests so that the negative predictive value of the test is almost 100% (excluding those with window period infections). The downside to having a sensitive screening test is that false positive results may occur in a small percentage of positive specimens, which is why international guidelines recommend that all positive HIV ELISA tests need to be confirmed by a second ...

Lab Update 18.2 - Role Of Cardiac Troponin Testing In COVID-19

Jul 01, 2020 | Chemical Pathology

Increased high-sensitive cardiac troponin (hs-cTn) is a marker of myocardial injury, irrespective of the mechanism, and does not equate to acute myocardial infarction (MI)....

Lab Update 18.1 - Role Of Inflammatory Marker Testing In COVID-19

Jun 01, 2020 | Chemical Pathology

Accumulating evidence suggests that inflammatory responses play a critical role in the progression of COVID-19. The inflammatory response is triggered by rapid viral replication of SARS-CoV-2 and cellular destruction, leading to the recruitment of macrophages and monocytes and the induction and release of cytokines. These cytokines attract more immune cells and further activate the immune response, leading to a “cytokine storm”....

Lab Update 18 - Lab Monitoring Of Patients With COVID-19

Jun 01, 2020 | Chemical Pathology

The laboratory plays a crucial role in the diagnosis of COVID-19 through the use of real-time reverse transcription polymerase chain reaction (rRT-PCR) for the detection of unique sequences of viral RNA. Subsequently, it also provides critical haematological and biochemical tests for assessing disease severity and progression, as well as for monitoring therapeutic intervention....

Lab Update 16 - The Detection Rates Of Pathogens Using The Sexually Transmitted Diseases PCR

Feb 01, 2020 | Chemical Pathology

Sexually transmitted infections are associated with poor reproductive outcomes and increased transmission of HIV. In South Africa, limited data is available regarding the prevalence of the etiological agents of the genital discharge syndrome, in particular from the private sector. The STD PCR that is available at Ampath laboratories detects the following organisms associated with the genital discharge syndrome:Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma....

Lab Update 15 - The Genital Ulcer Multiplex PCR

Feb 01, 2020 | Chemical Pathology

The majority of genital ulcers are caused by sexually transmitted infections (STI). The pathogens most commonly responsible for genital ulcers include: Herpes simplex type 1 and 2, Treponema pallidum, Haemophilus ducreyi, Chlamydia trachomatis serovar L 1-3, as well as Klebsiella granulomatosis. The presence of genital ulcers increases the risk of acquiring HIV. These patients may also be co-infected with other sexually transmitted pathogens....

Lab Update 14 - Genetic Testing For FMR1 Disorders

Feb 01, 2020 | Chemical Pathology

The FMR1 disorders include fragile X syndrome (FXS), fragile X-associated tremor/ataxia syndrome (FXTAS), and fragile X-associated primary ovarian insufficiency (FXPOI). The FXS is the most common single gene cause of intellectual disability with an estimated prevalence of 1/4 000 to 1/6 000. Almost all cases are caused by the expansion of an unstable trinucleotide (triplet)(CGG) repeat in the 5’ untranslated region of the FMR1 gene. Genetic testing for FXS and related disorders is now offered at the Ampath Genetics Laboratory in Centurion....

Lab Update 13 - First Trimester Pre-Eclampsia Screening

Nov 02, 2019 | Chemical Pathology

Pre-eclampsia (PE) is a major cause of maternal and neonatal morbidity and mortality, especially at early-onset (delivery at <34w gestation). Complications of PE include intracranial haemorrhage, HELLP syndrome, eclampsia, pulmonary oedema, renal failure, abruptio placentae, foetal growth restriction, intrauterine foetal death and preterm birth. Maternal future risks include cardiovascular, cerebrovascular or renal disease. Future risks to offspring born from affected pregnancies include hypertension, coronary artery disease and insulin resistance. In a South-African context, the prevalence of PE and severe PE is reported as 5.75% and 1.43% respectively. Global prevalence of PE varies between 2-5%....

Lab Update 11 - Molecular Assay For ID Of Mycobacterium Species

Nov 01, 2019 | Chemical Pathology

Non-tuberculous mycobacteria (NTM) are free-living ubiquitous organisms. More than 200 different species of NTM have been identified by using molecular techniques. The pathogenic potential of different NTM varies. Accurate identification to species level and discrimination from Mycobacterium tuberculosis complex is thus essential in determining the clinical relevance and guiding patient management. The GenoType CM direct assay is a molecular test for the identification of M. tuberculosis complex as well as clinically relevant NTM directly from clinical specimens. This assay is an adjunct to Mycobacterial culture in any patient in which NTM disease is suspected and may be especially useful where microscopy of clinical specimens is positive f...

Lab Update 12 - Voriconazole

Sep 01, 2019 | Chemical Pathology

The pharmacokinetic and pharmacodynamic (PK/PD) variability of voriconazole makes it a difficult drug to dose. It has a narrow therapeutic index, meaning that there is a narrow margin between the levels needed for therapeutic activity and the levels at which toxicity occurs. To achieve potential efficacy, trough levels of between 1 and 5.5 mg/L are needed. In patients with severe infections e.g. multifocal or disseminated disease, CNS infection, or infection with a pathogen with elevated MICs, a trough level of 2-6 mg/L is recommended. The potential for toxicity, especially neurotoxicity, increases significantly at levels of ≥6 mg/L....

Lab Update 10 - Urine Methylhistamine

Jul 01, 2019 | Chemical Pathology

Histamine turnover increases due to increased activity (allergic reactions) or proliferation (mastocytosis) of mast cells or basophils. Histamine is released intermittently and has a short half-life, thus measurement of urine 1-methylhistamine (N-Tele-methylhistamine, 1-MHIS), a major metabolite of histamine, has better sensitivity and specificity. Urine 1-MHIS testing is available at Ampath Esoteric Sciences by GC-MS/MS methodology....

Lab Update 9 - Bacterial Vaginosis Panel

Jun 01, 2019 | Chemical Pathology

Bacterial vaginosis (BV) is a condition characterised by an alteration in vaginal flora and is one of the most common causes of vaginal discharge in women of reproductive age. Bacterial vaginosis is associated with an increased risk of contracting sexually transmitted infections, including HIV, the development of pelvic inflammatory disease, as well as poor reproductive outcomes, notably, preterm delivery. Timely diagnosis and treatment of BV is essential to avoid these complications....

Lab Update 8 - Molecular Testing Of Respiratory Pathogens

Jun 01, 2019 | Chemical Pathology

Multiplex PCR is the gold standard test for the detection of respiratory tract pathogens and provides a sensitivity and specificity that is far superior to traditional diagnostic methods. These tests have a rapid turnaround time (TAT), which impacts favourably on the management of the patient. Ampath has several different options for detecting respiratory pathogens. These include smaller, targeted panels and more comprehensive panels....